Aspirin is anantiplateletthat prevents thromboxane formation, thereforereducing platelet aggregation. In a myocardial infarction, this can reduce the size of a developing blood clot andenhance clot breakdownto decrease damage to the heart.5 Aspirin is given after a TIA as the majority are caused by ...
Antiplatelet drugs Percutaneous coronary intervention Related Conference ofDiabetic Complications February 24-25, 2025 34thEuropean Diabetes Congress London, UK February 24-25, 2025 20thInternational Conference on Endocrinology and Metabolic Disorders
Dec 13 2024 This Week in CardiologyUS doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers this week. ...